We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Moderna Inc | NASDAQ:MRNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.18 | -0.97% | 120.95 | 120.70 | 120.80 | 123.50 | 118.68 | 122.86 | 2,894,012 | 00:57:39 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Bancel Stephane | 2. Issuer Name and Ticker or Trading Symbol Moderna, Inc. [ MRNA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 11/2/2022 | M(1) | 40000 | A | $.99 | 5451946 | D | |||
Common Stock | 11/2/2022 | S(1) | 2435 | D | $148.91 (2) | 5449511 | D | |||
Common Stock | 11/2/2022 | S(1) | 5687 | D | $150.01 (3) | 5443824 | D | |||
Common Stock | 11/2/2022 | S(1) | 700 | D | $150.98 (4) | 5443124 | D | |||
Common Stock | 11/2/2022 | S(1) | 1076 | D | $152.03 (5) | 5442048 | D | |||
Common Stock | 11/2/2022 | S(1) | 15368 | D | $153.25 (6) | 5426680 | D | |||
Common Stock | 11/2/2022 | S(1) | 13567 | D | $154.16 (7) | 5413113 | D | |||
Common Stock | 11/2/2022 | S(1) | 1167 | D | $154.89 (8) | 5411946 | D | |||
Common Stock | 11/3/2022 | M(1) | 40000 | A | $.99 | 5451946 | D | |||
Common Stock | 11/3/2022 | S(1) | 2309 | D | $143.87 (9) | 5449637 | D | |||
Common Stock | 11/3/2022 | S(1) | 5096 | D | $144.89 (10) | 5444541 | D | |||
Common Stock | 11/3/2022 | S(1) | 8520 | D | $145.75 (11) | 5436021 | D | |||
Common Stock | 11/3/2022 | S(1) | 4613 | D | $146.65 (12) | 5431408 | D | |||
Common Stock | 11/3/2022 | S(1) | 3800 | D | $147.85 (13) | 5427608 | D | |||
Common Stock | 11/3/2022 | S(1) | 13762 | D | $148.86 (14) | 5413846 | D | |||
Common Stock | 11/3/2022 | S(1) | 1800 | D | $149.90 (15) | 5412046 | D | |||
Common Stock | 11/3/2022 | S(1) | 100 | D | $150.60 | 5411946 | D | |||
Common Stock | 11/3/2022 | S(16) | 10000 | D | $138.61 | 6644880 | I | See Footnote (17) | ||
Common Stock | 9050372 | I | See Footnote (18) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Right to Buy) | $.99 | 11/2/2022 | M (1) | 40000 | (19) | 8/19/2023 | Common Stock | 40000 | $0 | 2707155 | D | ||||
Stock Option (Right to Buy) | $.99 | 11/3/2022 | M (1) | 40000 | (19) | 8/19/2023 | Common Stock | 40000 | $0 | 2667155 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Bancel Stephane C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE, MA 02139 | X | Chief Executive Officer |
Signatures | ||
/s/ Brian Sandstrom, as Attorney-in-Fact | 11/4/2022 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Moderna Chart |
1 Month Moderna Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions